Lysine-Targeting Covalent Inhibition of Glutaminase Using Cyanopyrimidines

Xiwen Xiao, Hibiki Okuno, Saki Inoue, Naoki Zenmyo, Yuya Matsumoto, Emi Mishiro-Sato, Keiko Kano, Kazuaki Yoshimune, Shohei Uchinomiya, Akio Ojida · 2026

Read Lysine-Targeting Covalent Inhibition of Glutaminase Using Cyanopyrimidines by Xiwen Xiao, Hibiki Okuno, Saki Inoue, Naoki Zenmyo, Yuya Matsumoto, Emi Mishiro-Sato, Keiko Kano, Kazuaki Yoshimune, Shohei Uchinomiya, Akio Ojida (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13625595.txt.

Description

Xiwen Xiao led a team building a covalent blocker of a cancer enzyme in a 2026 paper. The enzyme controls how cells use glutamine, a fuel many cancers depend on. Faulty metabolism is a hallmark of cancer, yet lasting covalent blockers of metabolic enzymes are little explored. The team screened a family of reactive groups to find one that latches onto a specific amino acid building block.

Their chosen group bound the enzyme permanently in cancer cells, with excellent selectivity across the whole protein set. The blocker shut down glutamine use and killed cancer cells that depend on it. The authors present covalent targeting of this enzyme as a promising therapy route.

Catalog record

CREATORXiwen Xiao, Hibiki Okuno, Saki Inoue, Naoki Zenmyo, Yuya Matsumoto, Emi Mishiro-Sato, Keiko Kano, Kazuaki Yoshimune, Shohei Uchinomiya, Akio Ojida
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13625595

Browse the full library · About the Tower of Babel